Global Pipeline Review for Clinical Trials for Alzheimer's Disease 2020

DUBLIN, May 11, 2020 /PRNewswire/ -- The "Global Alzheimer's Disease Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The "Alzheimer's Disease Pipeline Highlights - 2020" report provides the most up-to-date information on key pipeline products in the global Alzheimer's Disease market. It covers emerging therapies for Alzheimer's Disease in active clinical development stages including early and late-stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Alzheimer's Disease pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Alzheimer's Disease pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Alzheimer's Disease pipeline products by company.

Short-term Launch Highlights:
Find out which Alzheimer's Disease pipeline products will be launched in the US and beyond to 2025.

Key topics covered:

    --  Alzheimer's Disease phase 3 clinical trial pipeline products
    --  Alzheimer's Disease phase 2 clinical trial pipeline products
    --  Alzheimer's Disease phase 1 clinical trial pipeline products
    --  Alzheimer's Disease preclinical research pipeline products
    --  Alzheimer's Disease discovery stage pipeline products
    --  Alzheimer's Disease pipeline products short-term launch highlights

For more information about this report visit https://www.researchandmarkets.com/r/bc0net

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-pipeline-review-for-clinical-trials-for-alzheimers-disease-2020-301056755.html

SOURCE Research and Markets